123
Participants
Start Date
September 30, 2016
Primary Completion Date
April 30, 2017
Study Completion Date
April 30, 2017
Testosterone Undecanoate
just hypogonadic patients enrolled received hormone replacement therapy with testosterone undecanoate 1000 mg/4ml intramuscular (IM) at baseline, after 6 weeks and 12 weeks after the first evaluation
University of Roma La Sapienza
OTHER